Drugs of Today 2009, 45(Suppl. B): 33-38 Copyright © 2009 Prous Science, S.A.U. or its licensors. All rights reserved. CCC: 1699-3993/2009 CHLAMYDIA TRACHOMATIS SEROVAR DISTRIBUTIONS IN RUSSIAN MEN AND WOMEN: A COMPARISON WITH DUTCH SEROVAR DISTRIBUTIONS V. Smelov 1,2 *, K.D. Quint 3 *, J. Pleijster 4 , P.H.M. Savelkoul 5 , K. Shalepo 6 , E. Shipitsyna 6 , M. Domeika 7 , A. Gorelov 1 , A. Savicheva 6 , W.G.V. Quint 3 , H.J.C. de Vries 8,9 , S. Ouburg 4 and S.A. Morré 4 1 Faculty of Medicine, St. Petersburg State University, St. Petersburg, Russia; 2 St. Petersburg State University Outpatient Clinic, St. Petersburg, Russia; 3 DDL Diagnostic Laboratory, Voorburg, the Netherlands; 4 Laboratory of Immunogenetics, Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands; 5 Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands; 6 Laboratory of Microbiology, D.O. Ott Research Institute of Obstetrics and Gynecology, St. Petersburg, Russia; 7 Department of Medical Sciences, Uppsala University, Uppsala, Sweden; 8 STI Outpatient Clinic, Municipal Health Service, Amsterdam, the Netherlands; 9 Department of Dermatology, Academic Medical Center, University of Amsterdam, the Netherlands 33 CONTENTS Summary ................................................................................................................................................................. 34 Introduction ............................................................................................................................................................ 34 Patients and methods ............................................................................................................................................ 34 Russian cohort ................................................................................................................................................... 34 Amplification, detection and genotyping using the CT–DT assay ................................................................. 34 Comparison with Dutch serovar distribution studies ..................................................................................... 35 Statistical analyses ............................................................................................................................................ 35 Results .................................................................................................................................................................... 35 Russian serogroups and serovars .................................................................................................................... 35 Comparison of the Russian and Dutch serogroups and serovars ................................................................. 35 Discussion ............................................................................................................................................................... 36 Conclusions ............................................................................................................................................................. 37 References ............................................................................................................................................................... 37 Correspondence: Vitaly Smelov, MD, PhD, Faculty of Medicine, St. Petersburg State University, 21 linia V.O., 8A, 199034 St. Petersburg, Russia. E-mail: vitsmelov@yahoo.com. *Authors contributed equally.